Novavax Still Rallying After Grant
The Grant That Continues To Rally the Stock
Novavax (NVAX) stock continues its ascent following yesterday's announcement that the firm was granted up to $384 million by the coalition for Epidemic Preparedness innovation.

We remind that the grant is to help the advancement in the clinical development of the firm’s SARS-CoV-2 (